Insulin therapy protects the central and peripheral nervous system of intensive care patients

Objective: To investigate the effectiveness of maintaining blood glucose levels below 6.1 mmol/L with insulin as prevention of secondary injury to the central and peripheral nervous systems of intensive care patients. Methods: The authors studied the effect of intensive insulin therapy on critical illness polyneuropathy (CIPNP), assessed by weekly EMG screening, and its impact on mechanical ventilation dependency, as a prospectively planned subanalysis of a large randomized, controlled trial of 1,548 intensive care patients. In the 63 patients admitted with isolated brain injury, the authors studied the impact of insulin therapy on intracranial pressure, diabetes insipidus, seizures, and long-term rehabilitation at 6 and 12 months follow-up. Results: Intensive insulin therapy reduced ventilation dependency (p = 0.0007; Mantel–Cox log rank test) and the risk of CIPNP (p < 0.0001). The risk of CIPNP among the 405 long-stay (≥7 days in intensive care unit) patients was lowered by 49% (p < 0.0001). Of all metabolic and clinical effects of insulin therapy, and corrected for known risk factors, the level of glycemic control independently explained this benefit (OR for CIPNP 1.26 [1.09 to 1.46] per mmol blood glucose, p = 0.002). In turn, prevention of CIPNP explained the ability of intensive insulin therapy to reduce the risk of prolonged mechanical ventilation (OR 3.75 [1.49 to 9.39], p = 0.005). In isolated brain injury patients, intensive insulin therapy reduced mean (p = 0.003) and maximal (p < 0.0001) intracranial pressure while identical cerebral perfusion pressures were obtained with eightfold less vasopressors (p = 0.01). Seizures (p < 0.0001) and diabetes insipidus (p = 0.06) occurred less frequently. At 12 months follow-up, more brain-injured survivors in the intensive insulin group were able to care for most of their own needs (p = 0.05). Conclusions: Preventing even moderate hyperglycemia with insulin during intensive care protected the central and peripheral nervous systems, with clinical consequences such as shortening of intensive care dependency and possibly better long-term rehabilitation.

[1]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[2]  F. Leijten,et al.  Critical illness polyneuropathy a review of the literature, definition and pathophysiology , 1994, Clinical Neurology and Neurosurgery.

[3]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[4]  C. Durbin,et al.  Oxford Textbook of Critical Care , 2000 .

[5]  C. Bolton,et al.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.

[6]  P. Heuschmann,et al.  Variation in the management of acute physiological parameters after ischaemic stroke: a European perspective , 2003, European journal of neurology.

[7]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[8]  W. Schaufeli,et al.  Simplified Therapeutic Intervention Scoring System: the TISS-28 items--results from a multicenter study. , 1996 .

[9]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[10]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[11]  J. Yates,et al.  Evaluation of patients with advanced cancer using the karnofsky performance status , 1980, Cancer.

[12]  A. Sutcliffe,et al.  The relationship between blood glucose, mean arterial pressure and outcome after severe head injury: an observational study. , 2002, Injury.

[13]  C. Bolton,et al.  The neurological complications of sepsis , 1993, Annals of neurology.

[14]  K. Butcher,et al.  Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. , 2003, Stroke.

[15]  Catherine M. Lee,et al.  Acquired neuromuscular disorders in the intensive care unit. , 2003, American journal of respiratory and critical care medicine.

[16]  J. Garnacho-Montero,et al.  Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients , 2001, Intensive Care Medicine.

[17]  S. Hagl,et al.  Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. , 2000, The Thoracic and cardiovascular surgeon.

[18]  F. Leijten,et al.  The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. , 1996, JAMA.

[19]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.